UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2018

 

Commission File Number 001-33042

 

ROSETTA GENOMICS LTD.

(Translation of registrant’s name into English)

 
10 Plaut Street, Science Park
Rehovot 76706, Israel
(Address of Principal Executive Offices) 

  

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:

 

Form 20-F x              Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):         ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):         ¨

                                   

 

 

 

 

 

  

Rosetta Genomics Ltd.

 

A copy of the notice for the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on April 6, 2018 is filed as Exhibit 99.1 hereto and incorporated by reference herein.

 

Exhibits

 

Exhibit

Number

  Description of Exhibit
     
99.1   Notice of extraordinary general meeting of shareholders of Rosetta Genomics Ltd., to be held on April 6, 2018.

 

 

 

 

 

  

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ROSETTA GENOMICS LTD.
   
Date: February 27, 2018  By:  /s/ Kenneth Berlin
   

Kenneth Berlin

Chief Executive Officer and President  

 

 

 

Rosetta Genomics (CE) (USOTC:ROSGQ)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Rosetta Genomics (CE) 차트를 더 보려면 여기를 클릭.
Rosetta Genomics (CE) (USOTC:ROSGQ)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Rosetta Genomics (CE) 차트를 더 보려면 여기를 클릭.